Related Experiment Video
Updated: Aug 21, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device
Michelle C Montpetit1, Jamile L Shammo, Jerome Loew
1Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois, USA.
Abstract:
An acquired form of sideroblastic anemia has been described in association with several drugs, especially anti-microbial agents. A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms. This patient's anemia resolved after discontinuation of the drug; he subsequently underwent an uncomplicated orthotopic heart transplant with no recurrence of anemia. As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy VI: Nursing Management
Heart Failure V: Medical Management
Endocarditis IV: Nursing Management
